<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">Influenza co-infection can lead to secondary pneumonia, which frequently drives mortality during influenza epidemics 
 <xref rid="b0060" ref-type="bibr">[12]</xref>, 
 <xref rid="b0065" ref-type="bibr">[13]</xref>, 
 <xref rid="b0070" ref-type="bibr">[14]</xref>. LAIV is safe and effective 
 <xref rid="b0075" ref-type="bibr">[15]</xref>, 
 <xref rid="b0080" ref-type="bibr">[16]</xref>, but it has been reported that it can also increase rates and density of pneumococcal colonisation 
 <xref rid="b0085" ref-type="bibr">[17]</xref>, 
 <xref rid="b0090" ref-type="bibr">[18]</xref> leading to a theoretical risk of increased pneumococcal transmission to susceptible groups 
 <xref rid="b0095" ref-type="bibr">[19]</xref>.
</p>
